aap: Seperation of Trauma & Orthopaedics no longer pursued
Due to the positive development of the business situation of aap Implants AG´s Trauma & Orthopaedics division, management and supervisory board have decided to not further pursue the June 2007 decision to separate both aap´s divisions Trauma & Orthopaedics and aap bio implants (medical biomaterials), but to develop both sectors also in the future under one roof.
For 2008 aap plans an organic growth of above 20 % starting from 2007 group revenue of EUR 28 million.
For further information, please contact:
aap Implantate AG |
| Lorenzweg 5 |
| D-12099 Berlin |
| X |
| Oliver Bielenstein | Nanette Hüdepohl |
| Director/CFO | Head of Corporate Communications and Legal Affairs |
Tel.: +49 30 750 19 - 140 | Tel.: +49 30 75019 - 133 |
Fax: +49 30 750 19 - 290 | Fax: +49 30 75019 - 290 |
| X |
| WKN 506660, ISIN DE0005066609 |
| Prime Standard/Regulated Market |
| Traded at all German Stock Exchanges |
Print this page
